A reverse passive agglutination method was developed to detect soluble antigens of Legionella spp. By this method Legionella antigens were detected in urine specimens from 14 of 15 antigenuric patients with clinically diagnosed Legionnaires disease and in none of 263 urine samples from healthy subjects or patients with urinary tract infections. Intra-genus cross-reactivity was observed only between L. pneumophila serogroups 2, 3, and 6. The Legionella reverse passive agglutination method was also evaluated with reference to reagent concentrations, test conditions, and subjectivity of reading test results. The method is rapid and does not require special equipment.
There are currently three established methods for laboratory diagnosis of Legionnaires disease: indirect fluorescent antibody, direct fluorescent antibody, and culture isolation. The indirect fluorescent antibody test may not seroconvert until 4 to 6 weeks after the onset of disease, and its diagnostic value is diminished when immunosuppressed patients are tested. Both direct fluorescent antibody and culture methods require clinical specimens often obtained by invasive procedures (2, 4) . A need remains for a rapid and practical diagnostic method that is sensitive to recent legionellosis but negative for past infection or exposure. An attractive diagnostic approach is the detection of Legionella antigens in urine specimens. This has been achieved by enzyme immunoassay (1, 8) , radioimmunoassay (5) , reverse passive hemagglutination (7) , and coagglutination (9), but no methods are yet routinely applied. This paper describes the preliminary development of a rapid and practical reverse passive agglutination (RPA) method based on agglutination of the antibody-sensitized protein A-bearing Staphylococcus aureus in the presence of Legionella-soluble antigens. For healthy subjects and non-Legionnaires disease patients, the initial tests showed nonspecific agglutination in 25% of the urine samples. There was no correlation of this nonspecific reactivity with the type of urine specimen (normal or infected) or with urine pH (range, 5.2 to 8.2). Single or repeated preadsorption of urine with 10 to 50% (vol/vol) S. aureus suspensions eliminated some, but not all nonspecific reactions. The nonspecific agglutinator was stable at 56°C for 30 min but was inactivated by incuba- RPA is relatively sensitive (as compared with radioimmunoassay), detecting Legionella antigenuria in 14 of 15 patients with clinically diagnosed Legionnaires disease who were also positive for Legionella antigenuria by radioimmunoassay. Urine specimens did not require concentration before being tested. The nonlegionellosis control group, consisting of 263 urine specimens from healthy subjects or patients with urinary tract infections, was nonreactive by RPA, indicating high specificity and lack of interference by whole or soluble antigens from various gram-negative and gram-positive bacteria, other antibody-coated bacteria, and nonspecific antibody. There was no intra-genus cross-reactivity except when high concentrations of L. pneumophila serogroup 3-soluble antigens were tested with serogroups 2 and 6 RPA reagents. This cross-reactivity was not evident in heterologous inhibition studies, suggesting that the serogroup 3-soluble antigen preparation contains a low proportion of serogroups 2 and 6 cross-reactive antigens.
MATERIALS AND METHODS
Although the RPA method was standardized in its ability to detect soluble Legionella antigens at minimum concentrations of 30 to 50 ng of protein content per ml, heat stability studies suggest that the antigen detected by RPA is probably not protein. Antigen characterization studies are in progress. The ease with which the reaction can be inhibited by low concentrations of homologous antibody suggests also that Legionella-soluble antigens may have a low valency and that RPA is unlikely to detect Legionellasoluble antigens in antibody-excess immune complexes. This necessitates periodic removal by centrifugation of free IgG which may dissociate from the RPA reagents during storage periods longer than 4 months. It is suggested that known soluble antigens be titrated as controls to ensure a consistent level of sensitivity.
Further experience with RPA in clinical laboratories is required to more fully assess its sensitivity and specificity in the rapid diagnosis of Legionnaires disease, especially as related to the dynamics of antigen excretion during acute legionellosis and following treatment. The speed, economy, and practicality of the method should make it useful to both small hospital laboratories as well as reference centers.
